Search Results
Breaking down the costs of Biogen's billion-dollar Alzheimer's drug
Evidence to approve Biogen's Alzheimer's drug was not 'sufficient': Penn's Dr. Jason Karlawi
Cautious on Biogen's Alzheimer’s drug due to uncertainty around cost, reimbursement, access: Wedbush
FDA approves controversial Biogen Alzheimer's drug | DW News
FDA ‘abandoned its responsibility’ in approving Biogen Alzheimer’s drug: Doctor
Biogen CEO on FDA approval for its Alzheimer's drug
Analyst on what Biogen's Alzheimer's drug means for the company
Biogen reopens following FDA approval of company's Alzheimer drug
Why this analyst remains a 'skeptic' on Biogen's new Alzheimer's drug
United States approves first Alzheimer's drug in 18 years, Biogen's aducanumab | ABC News
Analysis: Alzheimer's Drug Treamtent Costs Patients $75,000 Per Year
FDA's historic approval of Biogen's Alzheimer's drug
